articleNeoplasiaFeb 1, 2008GOLD OA

Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer

University of Michigan–Ann Arbor · Michigan Center for Translational Pathology · +1 more institution

PubMed
Indexed incrossrefdoajpubmed

Abstract

TMPRSS2-ERG gene fusions are the predominant molecular subtype of prostate cancer. Here, we explored the role of TMPRSS2-ERG gene fusion product using in vitro and in vivo model systems. Transgenic mice expressing the ERG gene fusion product under androgen-regulation develop mouse prostatic intraepithelial neoplasia (PIN), a precursor lesion of prostate cancer. Introduction of the ERG gene fusion product into primary or immortalized benign prostate epithelial cells induced an invasion-associated transcriptional program but did not increase cellular proliferation or anchorage-independent growth. These results suggest that TMPRSS2-ERG may not be sufficient for transformation in the absence of secondary molecular…

No related works found for this paper.

Funding